Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine.
Identifieur interne : 001984 ( Main/Exploration ); précédent : 001983; suivant : 001985Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine.
Auteurs : Claudia Chauvet [France] ; Virginie Lardeux ; Steven R. Goldberg ; Mohamed Jaber ; Marcello SolinasSource :
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [ 1740-634X ] ; 2009.
Descripteurs français
- KwdFr :
- Animaux (MeSH), Autoadministration (MeSH), Cocaïne (administration et posologie), Comportement toxicomaniaque (psychologie), Environnement (MeSH), Extinction (psychologie) (effets des médicaments et des substances chimiques), Facteurs temps (MeSH), Hébergement animal (MeSH), Mâle (MeSH), Prévention secondaire (MeSH), Rat Sprague-Dawley (MeSH), Rats (MeSH), Signaux (MeSH), Stress physiologique (MeSH), Troubles liés à la cocaïne (prévention et contrôle), Yohimbine (pharmacologie).
- MESH :
- administration et posologie : Cocaïne.
- effets des médicaments et des substances chimiques : Extinction (psychologie).
- pharmacologie : Yohimbine.
- prévention et contrôle : Troubles liés à la cocaïne.
- psychologie : Comportement toxicomaniaque.
- Animaux, Autoadministration, Environnement, Facteurs temps, Hébergement animal, Mâle, Prévention secondaire, Rat Sprague-Dawley, Rats, Signaux, Stress physiologique.
English descriptors
- KwdEn :
- Animals (MeSH), Behavior, Addictive (psychology), Cocaine (administration & dosage), Cocaine-Related Disorders (prevention & control), Cues (MeSH), Environment (MeSH), Extinction, Psychological (drug effects), Housing, Animal (MeSH), Male (MeSH), Rats (MeSH), Rats, Sprague-Dawley (MeSH), Secondary Prevention (MeSH), Self Administration (MeSH), Stress, Physiological (MeSH), Time Factors (MeSH), Yohimbine (pharmacology).
- MESH :
- chemical , administration & dosage : Cocaine.
- drug effects : Extinction, Psychological.
- chemical , pharmacology : Yohimbine.
- prevention & control : Cocaine-Related Disorders.
- psychology : Behavior, Addictive.
- Animals, Cues, Environment, Housing, Animal, Male, Rats, Rats, Sprague-Dawley, Secondary Prevention, Self Administration, Stress, Physiological, Time Factors.
Abstract
Whereas earlier studies have focused on the preventive effects of enriched environments (EE) in drug addiction, in a recent study we suggested that EE can also have 'curative' effects. In fact, we found that cocaine addiction-related behaviors can be eliminated by housing cocaine-treated mice in EE during periods of forced abstinence. However, those results were obtained with two simple models of addiction, conditioned place preference (CPP), and behavioral sensitization. In this study, we used intravenous drug self-administration procedures in rats to further investigate the beneficial effects of EE on cocaine addiction in a reinstatement model of relapse. Singly housed rats learned to self-administer cocaine during 10 consecutive daily sessions (0.6 mg/injection, 6 h/day). They were then housed three per cage in either standard environments (SE) or EE and were kept abstinent in the animal facility until testing for extinction and reinstatement. We found that 30 days of EE significantly and consistently reduced cocaine seeking during a 6-h extinction session. In addition, EE significantly reduced cue- and stress-induced reinstatement. Surprisingly, given our earlier results in mice with CPP, EE did not reduce cocaine-induced reinstatement regardless of the level of exposure to cocaine and the duration of the period of abstinence and exposure to EE. Altogether, these results support the hypothesis that EE can reduce cocaine-induced craving and highlight the importance of positive life conditions in facilitating abstinence and preventing relapse to cocaine addiction.
DOI: 10.1038/npp.2009.127
PubMed: 19741591
PubMed Central: PMC3178884
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine.</title><author><name sortKey="Chauvet, Claudia" sort="Chauvet, Claudia" uniqKey="Chauvet C" first="Claudia" last="Chauvet">Claudia Chauvet</name><affiliation wicri:level="4"><nlm:affiliation>Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, CNRS, Poitiers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, CNRS, Poitiers</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Poitou-Charentes</region><settlement type="city">Poitiers</settlement></placeName><orgName type="university">Université de Poitiers</orgName></affiliation></author><author><name sortKey="Lardeux, Virginie" sort="Lardeux, Virginie" uniqKey="Lardeux V" first="Virginie" last="Lardeux">Virginie Lardeux</name></author><author><name sortKey="Goldberg, Steven R" sort="Goldberg, Steven R" uniqKey="Goldberg S" first="Steven R" last="Goldberg">Steven R. Goldberg</name></author><author><name sortKey="Jaber, Mohamed" sort="Jaber, Mohamed" uniqKey="Jaber M" first="Mohamed" last="Jaber">Mohamed Jaber</name></author><author><name sortKey="Solinas, Marcello" sort="Solinas, Marcello" uniqKey="Solinas M" first="Marcello" last="Solinas">Marcello Solinas</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19741591</idno><idno type="pmid">19741591</idno><idno type="doi">10.1038/npp.2009.127</idno><idno type="pmc">PMC3178884</idno><idno type="wicri:Area/Main/Corpus">001921</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001921</idno><idno type="wicri:Area/Main/Curation">001921</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001921</idno><idno type="wicri:Area/Main/Exploration">001921</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine.</title><author><name sortKey="Chauvet, Claudia" sort="Chauvet, Claudia" uniqKey="Chauvet C" first="Claudia" last="Chauvet">Claudia Chauvet</name><affiliation wicri:level="4"><nlm:affiliation>Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, CNRS, Poitiers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, CNRS, Poitiers</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Poitou-Charentes</region><settlement type="city">Poitiers</settlement></placeName><orgName type="university">Université de Poitiers</orgName></affiliation></author><author><name sortKey="Lardeux, Virginie" sort="Lardeux, Virginie" uniqKey="Lardeux V" first="Virginie" last="Lardeux">Virginie Lardeux</name></author><author><name sortKey="Goldberg, Steven R" sort="Goldberg, Steven R" uniqKey="Goldberg S" first="Steven R" last="Goldberg">Steven R. Goldberg</name></author><author><name sortKey="Jaber, Mohamed" sort="Jaber, Mohamed" uniqKey="Jaber M" first="Mohamed" last="Jaber">Mohamed Jaber</name></author><author><name sortKey="Solinas, Marcello" sort="Solinas, Marcello" uniqKey="Solinas M" first="Marcello" last="Solinas">Marcello Solinas</name></author></analytic><series><title level="j">Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</title><idno type="eISSN">1740-634X</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term><term>Behavior, Addictive (psychology)</term><term>Cocaine (administration & dosage)</term><term>Cocaine-Related Disorders (prevention & control)</term><term>Cues (MeSH)</term><term>Environment (MeSH)</term><term>Extinction, Psychological (drug effects)</term><term>Housing, Animal (MeSH)</term><term>Male (MeSH)</term><term>Rats (MeSH)</term><term>Rats, Sprague-Dawley (MeSH)</term><term>Secondary Prevention (MeSH)</term><term>Self Administration (MeSH)</term><term>Stress, Physiological (MeSH)</term><term>Time Factors (MeSH)</term><term>Yohimbine (pharmacology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux (MeSH)</term><term>Autoadministration (MeSH)</term><term>Cocaïne (administration et posologie)</term><term>Comportement toxicomaniaque (psychologie)</term><term>Environnement (MeSH)</term><term>Extinction (psychologie) (effets des médicaments et des substances chimiques)</term><term>Facteurs temps (MeSH)</term><term>Hébergement animal (MeSH)</term><term>Mâle (MeSH)</term><term>Prévention secondaire (MeSH)</term><term>Rat Sprague-Dawley (MeSH)</term><term>Rats (MeSH)</term><term>Signaux (MeSH)</term><term>Stress physiologique (MeSH)</term><term>Troubles liés à la cocaïne (prévention et contrôle)</term><term>Yohimbine (pharmacologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cocaine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cocaïne</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Extinction, Psychological</term></keywords><keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Extinction (psychologie)</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Yohimbine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Yohimbine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cocaine-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Troubles liés à la cocaïne</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Comportement toxicomaniaque</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Behavior, Addictive</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cues</term><term>Environment</term><term>Housing, Animal</term><term>Male</term><term>Rats</term><term>Rats, Sprague-Dawley</term><term>Secondary Prevention</term><term>Self Administration</term><term>Stress, Physiological</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Autoadministration</term><term>Environnement</term><term>Facteurs temps</term><term>Hébergement animal</term><term>Mâle</term><term>Prévention secondaire</term><term>Rat Sprague-Dawley</term><term>Rats</term><term>Signaux</term><term>Stress physiologique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Whereas earlier studies have focused on the preventive effects of enriched environments (EE) in drug addiction, in a recent study we suggested that EE can also have 'curative' effects. In fact, we found that cocaine addiction-related behaviors can be eliminated by housing cocaine-treated mice in EE during periods of forced abstinence. However, those results were obtained with two simple models of addiction, conditioned place preference (CPP), and behavioral sensitization. In this study, we used intravenous drug self-administration procedures in rats to further investigate the beneficial effects of EE on cocaine addiction in a reinstatement model of relapse. Singly housed rats learned to self-administer cocaine during 10 consecutive daily sessions (0.6 mg/injection, 6 h/day). They were then housed three per cage in either standard environments (SE) or EE and were kept abstinent in the animal facility until testing for extinction and reinstatement. We found that 30 days of EE significantly and consistently reduced cocaine seeking during a 6-h extinction session. In addition, EE significantly reduced cue- and stress-induced reinstatement. Surprisingly, given our earlier results in mice with CPP, EE did not reduce cocaine-induced reinstatement regardless of the level of exposure to cocaine and the duration of the period of abstinence and exposure to EE. Altogether, these results support the hypothesis that EE can reduce cocaine-induced craving and highlight the importance of positive life conditions in facilitating abstinence and preventing relapse to cocaine addiction.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19741591</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1740-634X</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>13</Issue><PubDate><Year>2009</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</Title><ISOAbbreviation>Neuropsychopharmacology</ISOAbbreviation></Journal><ArticleTitle>Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine.</ArticleTitle><Pagination><MedlinePgn>2767-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/npp.2009.127</ELocationID><Abstract><AbstractText>Whereas earlier studies have focused on the preventive effects of enriched environments (EE) in drug addiction, in a recent study we suggested that EE can also have 'curative' effects. In fact, we found that cocaine addiction-related behaviors can be eliminated by housing cocaine-treated mice in EE during periods of forced abstinence. However, those results were obtained with two simple models of addiction, conditioned place preference (CPP), and behavioral sensitization. In this study, we used intravenous drug self-administration procedures in rats to further investigate the beneficial effects of EE on cocaine addiction in a reinstatement model of relapse. Singly housed rats learned to self-administer cocaine during 10 consecutive daily sessions (0.6 mg/injection, 6 h/day). They were then housed three per cage in either standard environments (SE) or EE and were kept abstinent in the animal facility until testing for extinction and reinstatement. We found that 30 days of EE significantly and consistently reduced cocaine seeking during a 6-h extinction session. In addition, EE significantly reduced cue- and stress-induced reinstatement. Surprisingly, given our earlier results in mice with CPP, EE did not reduce cocaine-induced reinstatement regardless of the level of exposure to cocaine and the duration of the period of abstinence and exposure to EE. Altogether, these results support the hypothesis that EE can reduce cocaine-induced craving and highlight the importance of positive life conditions in facilitating abstinence and preventing relapse to cocaine addiction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chauvet</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, CNRS, Poitiers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lardeux</LastName><ForeName>Virginie</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Solinas</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZIA DA000001-25</GrantID><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA DA000003-24</GrantID><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neuropsychopharmacology</MedlineTA><NlmUniqueID>8904907</NlmUniqueID><ISSNLinking>0893-133X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>2Y49VWD90Q</RegistryNumber><NameOfSubstance UI="D015016">Yohimbine</NameOfSubstance></Chemical><Chemical><RegistryNumber>I5Y540LHVR</RegistryNumber><NameOfSubstance UI="D003042">Cocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016739" MajorTopicYN="N">Behavior, Addictive</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003042" MajorTopicYN="N">Cocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019970" MajorTopicYN="N">Cocaine-Related Disorders</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003463" MajorTopicYN="Y">Cues</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="Y">Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005108" MajorTopicYN="N">Extinction, Psychological</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006799" MajorTopicYN="N">Housing, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="Y">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012646" MajorTopicYN="N">Self Administration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="Y">Stress, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015016" MajorTopicYN="N">Yohimbine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19741591</ArticleId><ArticleId IdType="pii">npp2009127</ArticleId><ArticleId IdType="doi">10.1038/npp.2009.127</ArticleId><ArticleId IdType="pmc">PMC3178884</ArticleId><ArticleId IdType="mid">NIHMS320340</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Addiction. 2007 Dec;102(12):1863-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18031422</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 May 10;447(7141):178-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17468743</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Clin Psychopharmacol. 2008 Apr;16(2):165-77</Citation><ArticleIdList><ArticleId IdType="pubmed">18489020</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2008 Aug;31(2):159-68</Citation><ArticleIdList><ArticleId IdType="pubmed">18585920</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2008 Nov 3;193(1):48-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18534693</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17145-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18955698</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16829-30</Citation><ArticleIdList><ArticleId IdType="pubmed">18974216</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Pharmacol. 2008 Dec;19(8):777-85</Citation><ArticleIdList><ArticleId IdType="pubmed">19020412</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 2009 Jan;91(3):473-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18824018</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2009;56 Suppl 1:63-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18692512</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2009;56 Suppl 1:48-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18722390</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Jan;66(1):88-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19124692</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2009 Feb 1;65(3):191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19006788</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Mar 5;458(7234):25-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19262648</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2009 Apr;34(5):1102-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18463628</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2009 Apr;203(3):561-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19005643</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2009 May 15;65(10):851-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19181308</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 2009 May;92(3):377-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19463254</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2007 May 24;54(4):508-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17521565</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2009 Oct 1;104 Suppl 1:S70-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19136222</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2008 Jan;195(4):605-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17891381</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 2000 Feb;35(2):79-95</Citation><ArticleIdList><ArticleId IdType="pubmed">10611634</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12880-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11070096</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2000 Dec;153(1):31-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11255927</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2000 Dec;1(3):191-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11257907</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2001 Apr;155(1):18-26</Citation><ArticleIdList><ArticleId IdType="pubmed">11374332</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2001 May;155(3):278-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11432690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Jul 12;412(6843):141-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2001 Dec;158(4):343-59</Citation><ArticleIdList><ArticleId IdType="pubmed">11797055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Rev. 2002 Mar;54(1):1-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11870259</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 2002 Jun;301(3):785-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12023504</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurosci. 2002 Aug;16(3):387-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12193179</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2004 Apr;29(4):686-93</Citation><ArticleIdList><ArticleId IdType="pubmed">14872205</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Jun 1;55(11):1082-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15158427</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2004;47 Suppl 1:214-26</Citation><ArticleIdList><ArticleId IdType="pubmed">15464139</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2004 Oct;176(1):101-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15071719</ArticleId></ArticleIdList></Reference><Reference><Citation>NIDA Res Monogr. 1980 Mar;30:102-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6779164</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1981;75(2):134-43</Citation><ArticleIdList><ArticleId IdType="pubmed">6798603</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1982 Mar 12;215(4538):1394-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6278591</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 1988 Dec;27(3):897-904</Citation><ArticleIdList><ArticleId IdType="pubmed">3252176</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 1996 May;23(1):28-38</Citation><ArticleIdList><ArticleId IdType="pubmed">8723133</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 1996 May;23(1):39-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8723134</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1996 Jan;123(2):127-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8741935</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 1996 Jun;78(1):57-65</Citation><ArticleIdList><ArticleId IdType="pubmed">8793038</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2005 Apr 30;159(2):207-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15817184</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2005 May;179(2):366-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15551068</ArticleId></ArticleIdList></Reference><Reference><Citation>Addict Biol. 2006 Mar;11(1):2-38</Citation><ArticleIdList><ArticleId IdType="pubmed">16759333</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2006 Sep;7(9):697-709</Citation><ArticleIdList><ArticleId IdType="pubmed">16924259</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2006 Oct;31(10):2188-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16341025</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2006 Nov 1;174(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16920204</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2006 Nov;189(1):1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17019567</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2008 Apr;197(3):421-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18214445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Nouvelle-Aquitaine</li><li>Poitou-Charentes</li></region><settlement><li>Poitiers</li></settlement><orgName><li>Université de Poitiers</li></orgName></list><tree><noCountry><name sortKey="Goldberg, Steven R" sort="Goldberg, Steven R" uniqKey="Goldberg S" first="Steven R" last="Goldberg">Steven R. Goldberg</name><name sortKey="Jaber, Mohamed" sort="Jaber, Mohamed" uniqKey="Jaber M" first="Mohamed" last="Jaber">Mohamed Jaber</name><name sortKey="Lardeux, Virginie" sort="Lardeux, Virginie" uniqKey="Lardeux V" first="Virginie" last="Lardeux">Virginie Lardeux</name><name sortKey="Solinas, Marcello" sort="Solinas, Marcello" uniqKey="Solinas M" first="Marcello" last="Solinas">Marcello Solinas</name></noCountry><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Chauvet, Claudia" sort="Chauvet, Claudia" uniqKey="Chauvet C" first="Claudia" last="Chauvet">Claudia Chauvet</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001984 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001984 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19741591
|texte= Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19741591" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |